100 年度 癌症診療品質認證 醫院 檢討會
DESCRIPTION
100 年度 癌症診療品質認證 醫院 檢討會. 主辦機構:國民健康局 承辦機構: 國家衛生研究院 癌症研究所 TCOG. 1. 10/14/2011. 議程. 認證作業程序檢討 認證基準檢討 綜合討論. 2. 認證作業程序檢討. 3. 申請程序. - PowerPoint PPT PresentationTRANSCRIPT
-
*10010/14/2011 TCOG
-
*
-
*
-
1003110033148
101
-
*
305530 300504020
-
*
-
4(1)1 61 176 61 21 1 362 / 10
-
*-1
Rating A 10Rating A + Rating B 27Rating D + Rating E010Rating B()5Rating A Rating A + Rating B 11Rating D 3Rating E0 Rating A + Rating B 10Rating D 4Rating E 1
-
-2B1.22.43.23.3.33.53.6.23.6.33.104.15.1
-
1.11.21.31.4 2.12.2.12.2.22.32.42.52.6 3.13.23.3.13.3.23.3.33.3.43.43.53.6.13.6.23.7.13.7.23.83.93.6.33.6.43.10 4.14.24.34.44.54.6 5.15.2 6.1
-
*
-
*
1.1 Rating E Rating D Rating C50
-
*
1.1Rating BC Rating AB1.275
-
*
1.1
-
*
1.1
-
*
1.2 1234
-
*
1.2Rating E Rating D Rating C Rating C
-
*
1.2Rating BCRating AB
-
*
1.21-4
-
*
1.2
-
*
1.3 Rating E Rating DRating C Rating C
-
*
1.3Rating BCPDCARating ABPDCA 10097-99
-
*
1.312
-
*
1.4 1. 1AJCC 2 32. 4
-
*
1.4 1. 1AJCC 2 3
-
*
1.4
-
*
-
*
2.1 Rating ERating DRating D Rating C
-
*
2.1Rating BC Rating AB3000130002
-
*
2.120
-
*
2.110097
-
*
2.2 Rating ERating DRating D95%98% 90%95% Rating C98% 95%98%
-
*
2.2Rating B98%98%95% Rating A98 96-98
-
*
2.21.991A/B100%99 A97 B97 + 97 2E+F/D100%99 D97 E9797 F9797
-
*
2.3 Rating E Rating DRating CRating C Rating BC() Rating AB
-
*
2.3
-
*
2.3Rating A 3 1 2 3 3.
-
*
2.4 Rating E Rating DRating CRating C Rating BC Rating AB
-
*
2.4
-
*
2.41. 1234Class1~252.
-
*
2.5Class1~2 Rating E Rating DRating C Rating C80
-
*
2.5Rating BC80~95Rating AB95
-
*
2.5Class1~2Stage
-
*
2.51. 123 Class1~242.
-
*
2.51. K/L100 K L2. 10010%Class1-2
-
*
1962.13Tumor Size96983.4T Clinical T1151172.14Regional Lymph Nodes Examined991003.5N Clinical N1181193.6M Clinical M1201212.15Regional Lymph Nodes Positive1011023.7Clinical Stage Group122124
-
*
13.10T Pathologic T127129Other Staging System FIGO3.11N Pathologic N130131Other Staging SystemBCLC1013.12M Pathologic M132133Other Staging Systemhistology1013.13Pathologic Stage Group134136
-
2.42.5
-
*
2.6class0-3 Rating ERating D Rating C Rating BC Rating AB
-
*
2.6
-
*
2.61.1class 0-32class 1-225 class0334(:)56
-
3.1 Rating ERating DRating CRating CRating BC
-
3.1Rating AB /
-
3.11. 1 peer review article 2 3 42. Rating A Hodgkin lymphomaBDiffuse large B cell lymphomaFollicular lymphoma
-
3.2 Rating ERating DRating CRating C 70 Rating BC 1. 50% 2.
-
3.2Rating AB 1. 2. class 1~2
-
3.2
class 1~2 1 2 2
3
1,00061,001-2,00092,00112
-
3.2
2. 1 2 33. minimum requirement12345comorbidity6 regimensdose
-
*
3.2
4.CB 5. summary note6. 7.
-
regimenRTdose
-
3.3 3.3.1 Rating E20Rating D20%40%Rating C40%60%Rating B60%80%Rating A80%
-
3.3.11 2()TNMAJCC
-
100
3.3.1
12724 11 [27+1401/ 212] 100 18/2410075 Rating B2.3.2
-
3.3.2 Rating E20
Rating D20%40%
Rating C40%60%
Rating B60%80%
Rating A80%
-
3.3.2 1 2 3()
-
100
-
3.3.3 Rating E20Rating D20%40%Rating C40%60%Rating B60%80%Rating A80% 1. 1 2 3 2. Neoadjuvant
-
100
3.3.3
94322 211 [34+22+12+01/ 39] 10018/2710067 Rating B2..3.2
-
3.3.4Rating E20Rating D20%40%Rating C40%60%Rating B60%80%Rating A80% curative intent
-
3.3.4curative intent1 23 1C()
-
100
3.3.41.
9233 2311 [32+23+13+01/ 39] 10015/2710056 Rating C2. 3.2
-
3.4 Rating ERating DRating CRating C Rating BC70%
-
3.4Rating AB
-
3.4
-
3.424B 150 2()
-
1. 2. 3. 4. 5. 6.
-
7. () 8. 9. 10. 11. 12.
-
3.5 Rating ERating DRating CRating C 1. 2. 10%
-
3.5Rating BC 1. 2. 10%5% Rating AB10%20%10%
-
3.51.2.3. 1. 2.12303
-
3.5 1 2 312 3 4
-
3.55.1 conclusion or recommendation2process6.
-
3.6 3.6.1 Rating E Rating DRating CRating C
-
3.6.1Rating BC
Rating AB
-
3.6.1 (Adjuvant)(Neoadjuvant)(Concurrent Chemoradiotherapy , CCRT)
-
3.6.1 1 peer review article 2 3 4
-
3.6.2 Rating E Rating DRating CRating C3.6.1Prescription Rating BC Prescription Rating AB
-
3.6.2 1Prescription
-
overdose
-
*
3.6.3 Rating ERating DRating CRating CRating BC Rating AB
-
*
3.6.3
-
*
3.6.3
1. (1)(2)(3)ready to use2.
-
*
3.6.3
-
*
3.6.3
6.(spill kits)1
Class IIBClass III ()
-
*
3.6.3
2: () ()( )
-
Near missnear missing
-
*
3.6.4 Rating ERating DRating CRating CRating BC Rating AB
-
*
3.6.41.2. 3. 1.1 2
-
*
3.6.4
3.6.3
-
*
3.6.4
1
-
3.7 3.7.1 Rating ERating DRating CRating C 1. 2.Rating BC Rating AB
-
3.7.1 1 23. permanent section
-
3.7.2 Rating ERating DRating CRating C Rating BC
-
3.7.2Rating AB
-
3.8 Rating E Rating DRating CRating C Rating BC Rating AB
-
3.8 CTMRI
-
3.9 Rating E Rating DRating CRating C() (curative intent)Rating BCRating C (curative intent)
-
3.9Rating ABRating Ccurative intent 1. 2. 3. 4.
-
3.91. 1 2CTVPTV2.1peer review article23() 4
-
3.912CCE
-
3.10 Rating E Rating DRating CRating C Rating B Rating A
-
*
3.10 100
-
()
-
*
-
*
4.1123/4 Rating ERating DRating CRating C
-
*
4.1Rating BCRating AB /
-
*
4.1Port-AHickmanPICC/
-
*
4.13.6.4
-
*
4.2 Rating E Rating DRating CRating C Rating BC Rating AB
-
*
4.2 3.6.4
-
*
4.3 Rating E Rating DRating CRating CRating BRating A
-
*
4.31.3341 3.6.4
-
*
4.4Rating E Rating DRating CRating C
-
*
4.4Rating BC 208020 Rating AB 650%
-
*
4.4()20
-
*
4.41. 2. 6 6 3. 6
-
*
4.5 Rating E Rating DRating CRating C50
-
*
4.5Rating BC Class1~2400 Rating AB
-
*
4.5 10097
-
*
4.51122 3 4 3. C
-
*
4.6 Rating E Rating DRating CRating C Rating BC 1. 2.
-
*
4.6Rating AB
-
*
4.6
-
*
4.6
-
*
4.6AintakeBMI
-
*
-
*
5.1 Rating E Rating DRating CRating C Rating BC Rating AB
-
*
5.1 2 PDCA
-
*
5.2 Rating E Rating D Rating C Rating BC Rating AB
-
*
5.2
-
*
-
*
6.1 class1~22,000AIRBclass1~220001A
-
*
6.1IRB
-
1. 2.
-
*